These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31770)

  • 1. Thermal and vortical stability of purified human fibroblast interferon.
    Sedmak JJ; Jameson P; Grossberg SE
    Adv Exp Med Biol; 1978; 110():133-52. PubMed ID: 31770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of interferons.
    Sedmak JJ; Grossberg SE
    Tex Rep Biol Med; 1977; 35():198-204. PubMed ID: 29357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of physicochemical factors on the thermal inactivation of murine interferon.
    Jariwalla R; Grossberg SE; Sedmak JJ
    Arch Virol; 1975; 49(2-3):261-72. PubMed ID: 2143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chaotropic salts and protein denaturants on the thermal stability of mouse fibroblast interferon.
    Jariwalla RJ; Grossberg SE; Sedmak JJ
    J Gen Virol; 1977 Apr; 35(1):45-52. PubMed ID: 16081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to the stabilization of interferons.
    Sedmak JJ; Grossberg SE
    Tex Rep Biol Med; 1981-1982; 41():274-9. PubMed ID: 6817438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal stability of freeze-dried mammalian interferons. Analysis of freeze-drying conditions and accelerated storage tests for murine interferon.
    Jameson P; Greiff D; Grossberg SE
    Cryobiology; 1979 Aug; 16(4):301-14. PubMed ID: 226331
    [No Abstract]   [Full Text] [Related]  

  • 7. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing.
    Santana H; García G; Vega M; Beldarraín A; Páez R
    PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term stabilization of a new freeze-dried and albumin-free formulation of recombinant human interferon alpha 2b.
    Ruiz L; Reyes N; Sotolongo J; Aroche K; Aldana R; Báez R; Hardy E
    PDA J Pharm Sci Technol; 2006; 60(1):72-8. PubMed ID: 17089680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of human fibroblast interferon into two distinct classes by thiol exchange chromatography.
    Senussi OA; Cartwright T; Thompson P
    Arch Virol; 1979; 62(4):323-31. PubMed ID: 94537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of stabilizers and denaturants on the cold denaturation temperatures of proteins and implications for freeze-drying.
    Tang XC; Pikal MJ
    Pharm Res; 2005 Jul; 22(7):1167-75. PubMed ID: 16028018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures for stabilization of interferons.
    Sedmak JJ; Jameson P; Grossberg SE
    Methods Enzymol; 1981; 78(Pt A):591-5. PubMed ID: 6173648
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability of ribonuclease A in solution and the freeze-dried state.
    Townsend MW; DeLuca PP
    J Pharm Sci; 1990 Dec; 79(12):1083-6. PubMed ID: 2079655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam.
    Abdul-Fattah AM; Dellerman KM; Bogner RH; Pikal MJ
    J Pharm Sci; 2007 May; 96(5):1237-50. PubMed ID: 17455341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved freeze-dried bilirubin preparation.
    Doumas BT; Greiff D
    Dev Biol Stand; 1976 Oct; 36():325-31. PubMed ID: 1036328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of cycles for lyophilization.
    Greiff D
    Dev Biol Stand; 1992; 74():85-92. PubMed ID: 1375565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic modifications of human fibroblast and leukocyte interferons.
    Otto MJ; Sedmak JJ; Grossberg SE
    J Virol; 1980 Aug; 35(2):390-9. PubMed ID: 6160260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of human fibroblast interferon purified on concanavalin A-agarose.
    Heine JW; Mikulski AJ; Sulkowski E; Carter WA
    Arch Virol; 1978; 57(2):185-8. PubMed ID: 27163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.